Clinical neuropsychology is a specialized field that focuses on the assessment and treatment of individuals with neurological conditions or injuries that affect cognitive, emotional, and behavioral functioning. Clinical neuropsychologists use a variety of standardized tests, interviews, and observations to evaluate patients' cognitive abilities, such as attention, memory, language, executive functions, and visuospatial skills. They also assess emotional and behavioral symptoms, such as mood disturbances, personality changes, and impulse control problems. Based on their assessments, clinical neuropsychologists develop individualized treatment plans to help patients manage symptoms, improve functioning, and enhance quality of life. Treatment approaches may include cognitive rehabilitation, psychotherapy, medication management, and behavioral interventions. In addition to clinical practice, many neuropsychologists also engage in research to better understand the underlying mechanisms of brain function and dysfunction. Experimental neuropsychology is a related field that focuses on conducting research to investigate brain-behavior relationships in healthy individuals and those with neurological conditions. Experimental neuropsychologists use techniques such as neuroimaging (e.g., MRI, PET), electrophysiology (e.g., EEG), and cognitive testing to study brain structure and function, cognitive processes, and the effects of interventions on brain health and behavior.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom